Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 420Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
REVIEW ARTICLE

Digital clinical trial: A new norm in clinical research


 Depatment of Pharmacology, IPGMER, 244 AJC Bose Rd, Kolkata, West Bengal, India

Correspondence Address:
Sayanta Thakur,
Department of Pharmacology, IPGMER, 244 AJC Bose Rd, Kolkata- 700020, West Bengal
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/picr.PICR_278_20

The advent of digital technologies has been well blended with every aspect of human lives. Despite not being a new concept, the adoption of digital health technologies in clinical research, i.e., digital clinical trial has not been utilized extensively. However, with the prevailing COVID-19 pandemics, such transformation in clinical trial seems imminent. Few components of a trial such as consent, remote site monitoring, recruitment process which can be modified through digital technologies, are further specified by the regulatory authorities such as FDA and EMA. However, such novel method cannot be implemented without facing any limitations. All stakeholders pertinent to virtual clinical trial including the provider of digital technologies should align themselves with the patient-centric approach to propagate this concept. It is expected that such a transition is well accomplished and adopted by the sponsors without any compromise in scientific as well as ethical standard.
    
 

  Search Pubmed for
 
    -  Thakur S
    -  Lahiry S
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed123    
    PDF Downloaded4    

Recommend this journal